logo
welcome
The Motley Fool

The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now

The Motley Fool
Summary
Nutrition label

81% Informative

Johnson & Johnson remains one of the largest healthcare companies in the world by market cap, but several others could overtake it within the next decade .

Here are two prime candidates: Vertex Pharmaceuticals (NASDAQ: VRTX) and Intuitive Surgical .

The biotech could slow down considerably and still pull ahead of the pharmaceutical giant, but it's hard to imagine losing its top spot in the industry.

Intuitive Surgical recently earned clearance for the fifth generation of its da Vinci system in the U.S. This is one more reason why the company's performance in the next decade should be impressive enough for its market cap to leapfrog Johnson & Johnson's .

Consider when Nvidia made this list on April 15, 2005 ... if you invested $ 1,000 at the time of our recommendation, you would have $ 669,193 !.

VR Score

81

Informative language

82

Neutral language

7

Article tone

formal

Language

English

Language complexity

48

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

10

https://ycharts.com/companies/JNJ/chart/https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=517255a2-3c99-4f57-b653-e6d04d1dba51&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26source%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_pit%3D13885%26ftm_veh%3Darticle_pitch_feed_yahoo%26company%3DVertex%2520Pharmaceuticals&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=39cd523b-8ed4-48c3-8cc2-1ecb58d41472https://www.fool.com/investing/2024/08/03/prediction-2-stocks-that-will-be-worth-more-than-j/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=39cd523b-8ed4-48c3-8cc2-1ecb58d41472https://www.fool.com/legal/fool-disclosure-policy/https://ycharts.comhttps://www.fool.com/investing/2024/07/25/is-vertex-pharmaceuticals-monopoly-in-danger/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=39cd523b-8ed4-48c3-8cc2-1ecb58d41472https://www.fool.com/terms/b/blockbuster-drug/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=39cd523b-8ed4-48c3-8cc2-1ecb58d41472https://ycharts.com/companies/JNJ/market_caphttps://www.fool.com/author/20111/https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=517255a2-3c99-4f57-b653-e6d04d1dba51&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26amp%253Bsource%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D13885&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=39cd523b-8ed4-48c3-8cc2-1ecb58d41472

Affiliate links

no affiliate links